We are live on ! Find out more
NRD

Nebula Research & Development Portfolio holdings

AUM $1.17B
1-Year Est. Return 15.19%
This Fund
S&P 500
This Quarter Est. Return
+7.19%
1 Year Est. Return
+15.19%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$836M
AUM Growth
+$219M
Cap. Flow
+$188M
Cap. Flow %
22.5%
Top 10 Hldgs %
4.49%
Holding
1,220
New
441
Increased
247
Reduced
213
Closed
319

Top Buys

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$4.41M
2
AAP icon
Advance Auto Parts
AAP
+$4.15M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$3.96M
4
DLTR icon
Dollar Tree
DLTR
+$3.82M
5
MSFT icon
Microsoft
MSFT
+$3.74M

Top Sells

Rank Stock Value
1
BAC icon
Bank of America
BAC
+$2.82M
2
KO icon
Coca-Cola
KO
+$2.82M
3
GD icon
General Dynamics
GD
+$2.82M
4
ORCL icon
Oracle
ORCL
+$2.81M
5
HLNE icon
Hamilton Lane
HLNE
+$2.8M

Sector Composition

Rank Sector Weight
1 Technology 16.51%
2 Industrials 15.72%
3 Consumer Discretionary 15.68%
4 Healthcare 13.43%
5 Financials 10.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
YETI icon
51
Yeti Holdings
YETI
$3.86B
$2.79M 0.33%
67,905
+56,651
+503% +$2.22M
FAST icon
52
Fastenal
FAST
$54.7B
$2.7M 0.32%
+75,638
New +$2.56M
PM icon
53
Philip Morris
PM
$305B
$2.7M 0.32%
22,201
-4,697
-17% -$546K
BBWI icon
54
Bath & Body Works
BBWI
$4.13B
$2.65M 0.32%
+82,994
New +$2.75M
AXS icon
55
AXIS Capital
AXS
$8.63B
$2.65M 0.32%
33,257
+12,022
+57% +$900K
HPQ icon
56
HP
HPQ
$24.3B
$2.6M 0.31%
+72,358
New +$2.55M
CL icon
57
Colgate-Palmolive
CL
$73.6B
$2.57M 0.31%
+24,769
New +$2.52M
OSCR icon
58
Oscar Health
OSCR
$8.54B
$2.57M 0.31%
120,995
+5,489
+5% +$98.9K
BWXT icon
59
BWX Technologies
BWXT
$16.2B
$2.56M 0.31%
+23,554
New +$2.34M
TTWO icon
60
Take-Two Interactive
TTWO
$45.3B
$2.54M 0.3%
+16,505
New +$2.5M
TYL icon
61
Tyler Technologies
TYL
$13B
$2.51M 0.3%
+4,298
New +$2.42M
CVNA icon
62
Carvana
CVNA
$45.9B
$2.49M 0.3%
71,610
+56,650
+379% +$1.63M
FRT icon
63
Federal Realty Investment Trust
FRT
$11B
$2.49M 0.3%
+21,651
New +$2.42M
HWM icon
64
Howmet Aerospace
HWM
$115B
$2.48M 0.3%
24,702
+14,521
+143% +$1.31M
CAVA icon
65
CAVA Group
CAVA
$7.52B
$2.46M 0.29%
19,838
+16,159
+439% +$1.64M
BRBR icon
66
BellRing Brands
BRBR
$1.52B
$2.44M 0.29%
40,255
+19,205
+91% +$1.07M
CRC icon
67
California Resources
CRC
$4.51B
$2.44M 0.29%
46,418
+12,156
+35% +$615K
HESM icon
68
Hess Midstream
HESM
$5.11B
$2.41M 0.29%
68,204
+3,936
+6% +$144K
VEEV icon
69
Veeva Systems
VEEV
$31.6B
$2.37M 0.28%
+11,280
New +$2.23M
W icon
70
Wayfair
W
$12.5B
$2.35M 0.28%
41,887
+32,216
+333% +$1.55M
ORI icon
71
Old Republic International
ORI
$10.5B
$2.33M 0.28%
+65,690
New +$2.22M
SEIC icon
72
SEI Investments
SEIC
$12.2B
$2.32M 0.28%
33,592
-4,531
-12% -$302K
IOT icon
73
Samsara
IOT
$20.6B
$2.25M 0.27%
+46,676
New +$1.89M
IDYA icon
74
IDEAYA Biosciences
IDYA
$3.54B
$2.24M 0.27%
70,763
+38,393
+119% +$1.46M
QGEN icon
75
Qiagen
QGEN
$8.47B
$2.24M 0.27%
47,764
+38,025
+390% +$1.73M
1 2
3
4 5

Similar funds

SAF
Smith Anglin Financial Dallas, Texas $1.1B AUM 14.08% 1-Year Est. Return
GIM
Grassi Investment Management Santa Clara, California $1.26B AUM 23.4% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
PP
PrairieView Partners St. Paul, Minnesota $1.03B AUM 11.4% 1-Year Est. Return
FC
Forte Capital Rochester, New York $930M AUM 24.11% 1-Year Est. Return
HIP
HPS Investment Partners New York $1.52B AUM 19.81% 1-Year Est. Return
SC
Savoie Capital Chicago, Illinois $805M AUM 19.48% 1-Year Est. Return
BWA
Bordeaux Wealth Advisors Menlo Park, California $781M AUM 26.55% 1-Year Est. Return

Nebula Research & Development's Q3 2024 Portfolio in Review

As of Q3 2024, Nebula Research & Development held 1,220 positions worth $836M, up 35% from $618M the previous quarter. Its ten largest holdings account for 4.5% of the portfolio.

Nebula Research & Development deployed $188M of net new capital in Q3 2024, opening 441 new positions and adding to 247 existing holdings. Its largest new stake was BioMarin Pharmaceuticals: 52,699 shares worth $3.7M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Travelers Companies, an estimated $2.39M trimmed.

  • Nebula Research & Development's largest Q3 2024 buy was BioMarin Pharmaceuticals: 52,699 shares worth $3.7M.
  • Nebula Research & Development added most to Dollar Tree in Q3 2024, an estimated $3.82M increase.
  • Nebula Research & Development's biggest Q3 2024 reduction was Travelers Companies, cutting an estimated $2.39M.
  • Nebula Research & Development fully exited Bank of America in Q3 2024, selling an estimated $2.82M.
  • Nebula Research & Development's ten largest holdings make up 4.5% of its $836M portfolio in Q3 2024.
  • Nebula Research & Development opened 441 new positions and closed 319 in Q3 2024.
  • Nebula Research & Development's portfolio value rose 35% quarter-over-quarter to $836M.

Based on Nebula Research & Development's 13F filing for Q3 2024, filed 14 Nov 2024.